Cardiomyocyte apoptosis in hypertensive cardiomyopathy

被引:102
作者
González, A
Fortuño, MA
Querejeta, R
Ravassa, S
López, B
López, N
Díez, J
机构
[1] Univ Navarra, Fac Med, Div Fisiopatol Cardiovasc, Sch Med,Ctr Appl Med Res, E-31080 Pamplona, Spain
[2] Donostia Univ Hosp, San Sebastian, Spain
[3] Univ Navarra Clin, Sch Med, Dept Cardiol & Cardiovasc Surg, Pamplona, Spain
关键词
apoptosis; arterial hypertension; cardiomyocytes; heart failure;
D O I
10.1016/S0008-6363(03)00498-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is widely accepted that there are two principal forms of cell death; namely, necrosis and apoptosis. According to the classical view, necrosis is the major mechanism of cardiomyocyte death in cardiac diseases. However, in the past few years observations have been made showing that cardiomyocyte apoptosis occurs in diverse conditions and that apoptosis may be a contributing cause of the loss and functional abnormalities of cardiomyocytes with important pathophysiological consequences. In this regard, although a number of formal proofs are pending, it is conceivable that cardiomyocyte apoptosis may be an important variable in the clinical evolution of hypertensive cardiomyopathy. This review summarizes recent evidence demonstrating that cardiomyocyte apoptosis is abnormally stimulated in the heart of animals and humans with arterial hypertension. In addition, the potential mechanisms of cardiomyocyte apoptosis in hypertension and its detrimental impact on cardiac function will be addressed. Finally, the perspectives of strategies aimed to detect and modulate apoptosis of cardiomyocytes in hypertensive cardiomyopathy will be considered. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:549 / 562
页数:14
相关论文
共 181 条
[51]  
DIEZ J, 1995, J HYPERTENS, V13, P349
[52]   Clinical aspects of hypertensive myocardial fibrosis [J].
Díez, J ;
López, B ;
Gonzádlez, A ;
Querejeta, R .
CURRENT OPINION IN CARDIOLOGY, 2001, 16 (06) :328-335
[53]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[54]  
FADOK VA, 1992, J IMMUNOL, V148, P2207
[55]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[56]   Non-invasive in vivo imaging of myocardial apoptosis and necrosis [J].
Flotats, A ;
Carrió, I .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (04) :615-630
[57]   Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats -: Effects of AT1 blockade with losartan [J].
Fortuño, MA ;
Ravassa, S ;
Etayo, JC ;
Díez, J .
HYPERTENSION, 1998, 32 (02) :280-286
[58]   Clinical implications of apoptosis in hypertensive heart disease [J].
Fortuño, MA ;
González, A ;
Ravassa, S ;
López, B ;
Díez, J .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05) :H1495-H1506
[59]   Cardiomyocyte apoptotic cell death in arterial hypertension -: Mechanisms and potential management [J].
Fortuño, MA ;
Ravassa, S ;
Fortuño, A ;
Zalba, G ;
Díez, J .
HYPERTENSION, 2001, 38 (06) :1406-1412
[60]   p53-mediated upregulation of BAX gene transcription is not involved in Bax-α protein overexpression in the left ventricle of spontaneously hypertensive rats [J].
Fortuño, MA ;
Zalba, G ;
Ravassa, S ;
D'Elom, E ;
Beaumont, FJ ;
Fortuño, A ;
Díez, J .
HYPERTENSION, 1999, 33 (06) :1348-1352